The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies

The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies

Background: Due to the lack of comprehensive evidence based on prospective studies, the efficacy and safety of Janus Kinase (JAK) inhibitors (including tofacitinib, ruxolitinib, baricitinib, ritlecitinib and brepocitinib) for alopecia areata (AA) are yet to be proved.Methods: The systematic review a...

Full description

Bibliographic Details
Main Authors: Diqin Yan, Huaying Fan, Min Chen, Lin Xia, Simin Wang, Wenliang Dong, Qian Wang, Suping Niu, Huiying Rao, Liming Chen, Xiaoyan Nie, Yi Fang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Pharmacology
Subjects:
alopecia areata
JAK inhibitors
janus kinase inhibitors
tofacitinib
ruxolitinib
baricitinib
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.950450/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.950450/full

Similar Items